Source: ERJ Open Res, 6 (1) 00282-2019; 10.1183/23120541.00282-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Samuel P. Trethewey, John R. Hurst, Alice M. Turner. Pneumonia in exacerbations of COPD: what is the clinical significance?. ERJ Open Res, 6 (1) 00282-2019; 10.1183/23120541.00282-2019

Member's Comments

No comment yet.

Related content which might interest you: Pneumonia or exacerbation of COPD? Source: Eur Respir Monogr 2015; 69: 185-196 Year: 2015 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease Source: International Congress 2014 – COPD markers Year: 2014 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Pneumonia vs non-pneumonia in COPD exacerbations – different risks? Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly? Source: International Congress 2014 – COPD exacerbations Year: 2014 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Readmissions in COPD: The perspective of the patient Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013